Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:31 pm Purchase | 2025-03-31 | 13G | Mersana Therapeutics, Inc. MRSN | Schonfeld Strategic Advisors LLC | 7,614,065 6.110% | 7,614,065 (New Position) | Filing History |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Schonfeld Strategic Advisors LLC | 4,305,204 4.930% | -929,304 (-17.75%) | Filing History |
| 2025-05-15 4:31 pm Purchase | 2025-03-31 | 13G | Skye Bioscience, Inc. SKYE | Schonfeld Strategic Advisors LLC | 1,617,697 5.220% | 1,617,697 (New Position) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Fate Therapeutics, Inc. FATE | Schonfeld Strategic Advisors LLC | 7,794,513 6.800% | 7,794,513 (New Position) | Filing History |
| 2025-05-15 4:30 pm Sale | 2025-03-31 | 13G | Applied Therapeutics, Inc. APLT | Schonfeld Strategic Advisors LLC | 4,676,097 3.300% | -4,093,543 (-46.68%) | Filing History |
| 2025-02-14 4:16 pm Sale | 2024-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | Schonfeld Strategic Advisors LLC | 1,314,915 2.820% | -457,800 (-25.82%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Applied Therapeutics, Inc. APLT | Schonfeld Strategic Advisors LLC | 8,769,640 7.540% | 8,769,640 (New Position) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Schonfeld Strategic Advisors LLC | 5,234,508 6.160% | 5,234,508 (New Position) | Filing History |
| 2024-11-14 4:15 pm Purchase | 2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | Schonfeld Strategic Advisors LLC | 1,772,715 5.300% | 1,772,715 (New Position) | Filing History |
| 2024-02-14 4:31 pm Sale | 2023-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Schonfeld Strategic Advisors LLC | 119 0.180% | -3,091 (-96.30%) | Filing History |
| 2024-02-14 4:30 pm Sale | 2023-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG | Schonfeld Strategic Advisors LLC | 41,993 0.100% | -3,546,723 (-98.83%) | Filing History |
| 2023-02-14 4:32 pm Sale | 2022-12-31 | 13G | MarketWise, Inc. MKTW | Schonfeld Strategic Advisors LLC | 0 0.000% | -1,468,900 (Position Closed) | Filing History |
| 2023-02-14 4:31 pm Purchase | 2022-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Schonfeld Strategic Advisors LLC | 3,210 6.140% | 3,210 (New Position) | Filing History |
| 2023-02-14 4:30 pm Sale | 2022-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG | Schonfeld Strategic Advisors LLC | 3,588,716 7.990% | -1,121,757 (-23.81%) | Filing History |
| 2022-06-09 4:45 pm Purchase | 2022-05-31 | 13G | Grosvenor Capital Management, L.P. GCMG | Schonfeld Strategic Advisors LLC | 4,710,473 10.500% | 2,086,113 (+79.49%) | Filing History |
| 2022-02-15 4:07 pm Purchase | 2021-12-31 | 13G | MarketWise, Inc. MKTW | Schonfeld Strategic Advisors LLC | 1,468,900 5.840% | 1,468,900 (New Position) | Filing History |
| 2022-02-14 11:36 am Purchase | 2021-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG | Schonfeld Strategic Advisors LLC | 2,624,360 6.000% | 2,624,360 (New Position) | Filing History |
| 2022-02-14 11:35 am Purchase | 2021-12-31 | 13G | PubMatic, Inc. PUBM | Schonfeld Strategic Advisors LLC | 517,926 1.880% | 75,726 (+17.12%) | Filing History |
| 2022-02-14 11:34 am Purchase | 2021-12-31 | 13G | Churchill Capital Corp V CCV | Schonfeld Strategic Advisors LLC | 16,518 3.300% | 16,518 (New Position) | Filing History |
| 2021-02-16 1:29 pm Purchase | 2020-12-31 | 13G | PubMatic, Inc. PUBM | Schonfeld Strategic Advisors LLC | 442,200 7.490% | 442,200 (New Position) | Filing History |